As of 2026-03-12, the Relative Valuation of West Pharmaceutical Services Inc (WST) is 237.16 USD. This relative valuation is based on P/E multiples. With the latest stock price at 237.85 USD, the upside of West Pharmaceutical Services Inc based on Relative Valuation is -0.3%.
The range of the Relative Valuation is 220.98 - 249.79 USD.
| Range | Selected | |
| Trailing P/E multiples | 32.2x - 34.8x | 33.6x |
| Forward P/E multiples | 27.2x - 29.7x | 29.0x |
| Fair Price | 220.98 - 249.79 | 237.16 |
| Upside | -7.1% - 5.0% | -0.3% |
| Date | P/E |
| 2026-03-11 | 34.66 |
| 2026-03-10 | 34.07 |
| 2026-03-09 | 36.15 |
| 2026-03-06 | 35.83 |
| 2026-03-05 | 35.61 |
| 2026-03-04 | 36.26 |
| 2026-03-03 | 36.63 |
| 2026-03-02 | 36.61 |
| 2026-02-27 | 37.06 |
| 2026-02-26 | 36.29 |
| 2026-02-25 | 36.12 |
| 2026-02-24 | 35.76 |
| 2026-02-23 | 35.59 |
| 2026-02-20 | 35.14 |
| 2026-02-19 | 35.53 |
| 2026-02-18 | 36.18 |
| 2026-02-17 | 35.44 |
| 2026-02-13 | 36.50 |
| 2026-02-12 | 35.50 |
| 2026-02-11 | 35.87 |
| 2026-02-10 | 35.49 |
| 2026-02-09 | 36.27 |
| 2026-02-06 | 36.28 |
| 2026-02-05 | 33.75 |
| 2026-02-04 | 34.54 |
| 2026-02-03 | 33.65 |
| 2026-02-02 | 34.61 |
| 2026-01-30 | 33.68 |
| 2026-01-29 | 33.90 |
| 2026-01-28 | 34.37 |
| 2026-01-27 | 35.05 |
| 2026-01-26 | 35.18 |
| 2026-01-23 | 34.49 |
| 2026-01-22 | 36.11 |
| 2026-01-21 | 37.18 |
| 2026-01-20 | 36.50 |
| 2026-01-16 | 37.86 |
| 2026-01-15 | 40.71 |
| 2026-01-14 | 40.07 |
| 2026-01-13 | 39.61 |
| 2026-01-12 | 39.77 |
| 2026-01-09 | 40.15 |
| 2026-01-08 | 40.11 |
| 2026-01-07 | 40.57 |
| 2026-01-06 | 40.92 |
| 2026-01-05 | 40.66 |
| 2026-01-02 | 40.28 |
| 2025-12-31 | 40.09 |
| 2025-12-30 | 40.34 |
| 2025-12-29 | 40.16 |